|
Ralph Kauten serves as Chief Executive Officer of Quintessence Biosciences, Inc. In this role, Mr. Kauten brings together the resources necessary to build the company and managing the resources to achieve commercial success. Principal among these resources are 1) finances (both equity and debt) and 2) personnel to fill the open positions on the management team. Before joining Quintessence, Mr. Kauten spent 20 years working in various technical and managerial positions in the biotechnology industry. Most recently, Mr. Kauten was Chairman and President of PanVera Corporation, a drug discovery company providing innovative new products consisting of human drug target proteins and assays for high throughput screening. Mr. Kauten was one of three founders of PanVera, which is located in Madison, Wisconsin. Under Mr. Kauten's leadership, PanVera grew from a start-up company in 1992 with three employees to an award winning, rapidly growing and profitable company. In recognition of his performance as leader of PanVera, Mr. Kauten received the Ernst & Young Entrepreneur of the Year Award in 2001. Prior to PanVera, Mr. Kauten served as Vice President Finance, Chief Financial Officer, and Board Member at Promega Corporation. He played a leading role at Promega from the company's early days and was responsible for securing financing as well as overseeing the financial and administrative aspects of worldwide operations. Mr. Kauten has also served as a founder of Mirus Corporation a gene delivery company located in Madison, Wisconsin and continues to serve as Chairman of the Board of Directors. Mr. Kauten has Bachelor and Masters degrees in Business Administration. | 